Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,333.00
-41.00 (-2.98%)
Mar 12, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 96.8 billion as of March 11, 2026. Its market cap has decreased by -51.28% in one year.
Market Cap
96.80B
Enterprise Value
196.04B
Revenue
87.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,333.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 96.80B, a decrease of -59.19%. That is a compound annual growth rate of -6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 96.80B | -2.17% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 228.31B |
| Vaxcell-Bio Therapeutics | 190.71B |
| Macrogen | 178.34B |
| MedPacto | 175.83B |
| ENCell | 167.87B |
| iNtRON Biotechnology | 143.46B |
| CG Invites | 109.96B |
| IMB Dx | 96.72B |